WO2002087611B1 - Mittel humanen ursprungs zur vakzination gegen gd2-positive tumore - Google Patents
Mittel humanen ursprungs zur vakzination gegen gd2-positive tumoreInfo
- Publication number
- WO2002087611B1 WO2002087611B1 PCT/DE2001/004359 DE0104359W WO02087611B1 WO 2002087611 B1 WO2002087611 B1 WO 2002087611B1 DE 0104359 W DE0104359 W DE 0104359W WO 02087611 B1 WO02087611 B1 WO 02087611B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- ids
- origin
- tumours
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10059930.3 | 2000-11-23 | ||
DE2000159930 DE10059930A1 (de) | 2000-11-23 | 2000-11-23 | Mittel humanen Ursprungs zur Vakzination gegen GD2-pos. Tumore |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002087611A2 WO2002087611A2 (de) | 2002-11-07 |
WO2002087611A3 WO2002087611A3 (de) | 2003-07-31 |
WO2002087611B1 true WO2002087611B1 (de) | 2004-03-04 |
Family
ID=7665547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2001/004359 WO2002087611A2 (de) | 2000-11-23 | 2001-11-22 | Mittel humanen ursprungs zur vakzination gegen gd2-positive tumore |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE10059930A1 (de) |
WO (1) | WO2002087611A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
AT500650B1 (de) * | 2003-04-17 | 2009-11-15 | Altropus Gmbh | Immunogener rekombinanter antikörper |
GB0517878D0 (en) * | 2005-09-02 | 2005-10-12 | Bioinvent Int Ab | Immunotherapeutic treatment |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
DE102011054413A1 (de) * | 2011-10-12 | 2013-04-18 | Ernst-Moritz-Arndt-Universität Greifswald | Monoklonaler anti-Idiotyp-Antikörper Ganglidiomab |
KR102614642B1 (ko) * | 2014-06-04 | 2023-12-19 | 바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 | 강글리오사이드 gd2에 대한 사람 단클론 항체 |
CN116769723B (zh) * | 2023-08-09 | 2023-11-03 | 山东省成体细胞产业技术研究院有限公司 | 一种gd2嵌合抗原受体修饰的t细胞及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5653977A (en) * | 1993-09-09 | 1997-08-05 | Uab Research Foundation | Anti-idiotypic antibody that mimics the GD2 antigen |
WO1999002545A2 (en) * | 1997-07-08 | 1999-01-21 | Novopharm Biotech Inc. | Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
-
2000
- 2000-11-23 DE DE2000159930 patent/DE10059930A1/de not_active Withdrawn
-
2001
- 2001-11-22 WO PCT/DE2001/004359 patent/WO2002087611A2/de not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002087611A3 (de) | 2003-07-31 |
DE10059930A1 (de) | 2002-05-29 |
WO2002087611A2 (de) | 2002-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303173A2 (hu) | Csökkent immunogenitású, módosított anti-EGFR-ellenanyagok | |
DE69530415T2 (de) | Rekombinierte sequenzen des monoklonalen anti-idiotypischen antikörpers 3h1, diean dem menschlichen karzioembyonischen antigen liiert sind | |
AU2005232396B2 (en) | Vaccination against malignant melanoma using BCG and/or vaccinia | |
DE69635843T2 (de) | Monoklonaler anti-idiotypischer antikörper 11d10 aus der maus und methoden zu dessen verwendung | |
IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
DE69609188D1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
CA2441845A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
WO2000073430A2 (de) | Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind | |
DE69716240T2 (de) | Neue methode zur impfung sowie impfstoffe dafür, die eine epitopkodierende nukleinsäure und ein epitopenthaltende peptid beinhalten | |
AU768515B2 (en) | Use of antibodies for anticancer vaccination | |
WO2002087611B1 (de) | Mittel humanen ursprungs zur vakzination gegen gd2-positive tumore | |
EP1229936A2 (de) | Verwendung von anti-idiotypische antikörpern als impfstoffe gegen krebs | |
RU2001130068A (ru) | Антиидиотипические антитела к антителам, которые ингибируют связывание иммуноглобулина с его высокоаффинным рецептором | |
AT500650B1 (de) | Immunogener rekombinanter antikörper | |
WO2002081625A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
WO2002099062A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
EP0213581A2 (de) | Monoklonale Antikörper gegen tumorassoziierte Glykoproteine, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
WO2002090504A3 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
EP0825256B1 (de) | Hybridzelle und deren Verwendung zur Herstellung eines Arzneimittels zur Induktion einer Tumorimmunität | |
EP1506012A1 (de) | Verwendung eines impfstoffes zur aktiven immunisierung gegen krebs | |
US20060159693A1 (en) | Idiotypic vaccine | |
KR20170140784A (ko) | 파지 디스플레이 기술을 이용한 여드름 균에 특이적으로 결합하는 인간 항체 및 이의 용도 | |
EP1390057A4 (de) | Antikörper welche an antigene polypeptide binden, nukleinsäuren welche die antigene kodieren, und methode zur verwendung | |
WO2003020750A2 (de) | Antigen-mimotope und vakzine gegen krebserkrankungen | |
WO2002000822A3 (fr) | Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
B | Later publication of amended claims |
Effective date: 20030526 |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |